glp-1 injection pen FDA Approves First Generic Liraglutide for Weight Loss Considering GLP-1 drugs for weight

A novel human-based receptor antagonist of sustained action reveals body weight control by endogenous GLP-1

Hengrui, Kailera's GLP-1 pill posts encouraging efficacy but high side effect rates in late-stage China trials The GLP-1 pill being developed by Hengrui Pharma and Kailera Therapeutics posted decent results in two late-stage China-based trials one in obesity and the other Sign up to read this article for free

These studies are exploring potential benefits for conditions such as Alzheimers disease

Phase I studies of the safety, tolerability, pharmacokinetics and pharmacodynamics of the dual glucagon receptor/glucagon-like peptide-1 receptor agonist BI 456906

Like LIR, the race of patients involved in related clinical studies is relatively small

Zepbound has a list price of $1,086.37 , and its single-use vials have a cash price $299$449 per month, depending on dose